Hawthorne Effect assists clinical trials with the management of patient data, including in-home assessments and real-time data visibility. The company’s solutions are primarily offered through its Accelerate Clinical Trial platform, which includes 1) adaptive assessments for enabling comprehensive screening and follow-ups, 2) verified real-time data for multi-modal data collection and visibility, 3) intelligent matching for patient screening, and 4) universal enrollment for patient onboarding. The cloud platform is compliant with industry standards including 21 CFR Part 11 and GDPR.
In addition to its platform, Hawthorne also provides consulting services to its customers including patient recruitment, site design, and accelerated startup. Furthermore, the company maintains a network of healthcare professionals, called Hawthorne Heroes, to supplement its platform solution. These professionals support patient engagement and the accuracy of the data collected.
Key customers and partnerships
The company noted that, as of June 2024, it had completed 70+ studies, across 50 states (including outside of the US), and had a network of 4,000+ Hawthorne Heros.
The company supported Operation Warp Speed in the development of a Covid-19 vaccine, specifically in reaching out to patients and ensuring follow-ups during the pandemic
Funding and financials
Hawthorne raised USD 20 million in Series A funding in June 2021 led by NorthPond Ventures. The proceeds were to be used for expanding operations and scaling partnerships.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.